# A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial

> **NCT05946564** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 126 (estimated)

## Conditions studied

- ANCA Associated Vasculitis
- Rapidly Progressive Glomerulonephritis
- Crescentic Glomerulonephritis

## Interventions

- **DRUG:** Pioglitazone (ACTOS®)
- **DRUG:** Placebo of Pioglitazone

## Key facts

- **NCT ID:** NCT05946564
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-24
- **Primary completion:** 2027-04-24
- **Final completion:** 2027-10-24
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946564, "A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05946564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*